Cobalt ferrite nanoparticles tune magnetism, strain, and cancer-cell toxicity by composition

Engineers have long prized cobalt ferrite for its stubborn magnetism and its ability to squeeze itself when magnetized, but a new study shows that simply shifting the cobalt-to-iron ratio in the starting recipe can steer all of these properties at once. Researchers synthesized a series of nominal CoₓFe₃₋ₓO₄ nanomaterials, with x running from 0.5 to 1.1, using a sol–gel auto-combustion method and then annealed the powders at 600 °C. The work, published in Discover Nano, maps how nominal composition reshapes crystal structure, magnetic behavior, pellet-scale magnetostriction, and the growth of MCF-7 breast cancer cells in laboratory dishes, while carefully keeping the materials measurements and the biological assays as separate lines of evidence.

The structural analysis revealed a clear divide across the series. Rietveld refinement of X-ray diffraction patterns showed that the iron-rich compositions, x = 0.5 through 0.8, are mixed-phase materials containing cubic spinel ferrite together with a secondary α-Fe₂O₃ (hematite) phase, whereas x = 0.9 through 1.1 are predominantly single-phase spinel within the resolution of XRD. The hematite contribution was estimated to fall from roughly 25 percent at x = 0.5 to about 4 percent at x = 0.8, with the spinel fraction rising correspondingly from about 75 to 96 percent; these phase fractions are treated as semi-quantitative estimates. Crystallite sizes derived from XRD grew gradually from approximately 20 nm at x = 0.5 to about 30 nm at x = 1.1, with intermediate compositions near 22–28 nm. Electron microscopy reinforced the picture: iron-rich samples showed irregular, faceted grains with broad size dispersion, while the cobalt-rich Co₁.₁Fe₁.₉O₄ particles were predominantly equiaxed and rounded, consistent with the stabilization of the single-phase spinel and isotropic growth. High-resolution TEM lattice fringes of about 0.25 nm indexed to the (311) planes and about 0.29 nm to the (220) planes confirmed high crystallinity, and average particle sizes of 20–40 nm suggested largely single-crystalline nanoparticles that still aggregate through magnetic dipolar interactions.

Magnetization measurements at room temperature traced a non-monotonic path across the series. Saturation magnetization rose from 53.47 emu g⁻¹ at x = 0.5 to a maximum of 76.05 emu g⁻¹ at x = 1.0 before dipping to 68.99 emu g⁻¹ at x = 1.1. The authors note that all magnetization values were normalized to the total sample mass and not corrected for hematite content, so the mixed-phase compositions reflect the combined response of spinel and α-Fe₂O₃. The weaker net magnetic response of hematite at room temperature partly explains the lower values in iron-rich samples, while the decline at x = 1.1, despite no detectable hematite, points to factors intrinsic to the cobalt-rich spinel such as cation redistribution, surface-spin disorder, and magnetic anisotropy. Coercivity followed its own pattern, climbing with cobalt content to a peak of 1.86 kOe at x = 0.7 and then falling continuously at higher cobalt levels. The team links this maximum to the established strong magnetocrystalline anisotropy of cobalt ferrites, in which octahedrally coordinated Co²⁺ contributes through spin–orbit coupling, while cautioning that cobalt oxidation state and site occupancy were not directly quantified in these samples.

Low-temperature measurements sharpened the magnetic picture. Hysteresis loops recorded at 5 K up to 70 kOe showed marked enhancements in saturation magnetization, coercivity, and remanence relative to room temperature, reflecting suppressed thermal fluctuations and anisotropy-controlled spin alignment. The authors attribute the higher coercivity to enhanced magnetocrystalline and surface anisotropy, with frozen surface spins acting as pinning barriers, and note consistency with the Kneller law for single-domain nanoparticles. Field-cooled and zero-field-cooled curves measured between 5 K and 350 K for selected compositions never intersected, indicating blocking temperatures above 350 K, so the nanoparticles remain magnetically blocked at room temperature. The largest FC–ZFC separation occurred for x = 0.7, matching its maximum coercivity. Mössbauer spectroscopy added local-structure detail: all spectra showed magnetic sextets confirming ferrimagnetic ordering at ambient temperature, isomer shifts of about 0.25–0.41 mm/s confirmed high-spin Fe³⁺, and the relative spectral contribution of tetrahedral Fe³⁺ rose from roughly 38.6 percent at x = 0.5 to 89.2 percent at x = 1.1, which the authors interpret qualitatively as cation redistribution rather than exact site occupancies.

The magnetostriction results are the mechanical centerpiece. Measured on sintered, polished pellets with resistive strain gauges, the room-temperature longitudinal magnetostriction was negative for all compositions, as expected for cobalt ferrite, and peaked in magnitude at x = 0.7 with λ∥,max = −425 ppm at 7.5 kOe. The other compositions measured −350 ppm at 6.2 kOe (x = 0.5), −393 ppm at 7.3 kOe (x = 0.6), −320 ppm at 4.8 kOe (x = 0.9), and −287 ppm at 3.8 kOe (x = 1.0). The authors place this value near the highest magnetostriction reported for cobalt-ferrite ceramics, noting that dense CoFe₂O₄ typically shows about −212 ppm and that single crystals can approach roughly 600 ppm along ⟨100⟩. Importantly, the magnetostrictive maximum did not coincide with the maximum of the intrinsic magnetocrystalline anisotropy constant K₁, which the Law of Approach to Saturation placed at x = 1.0 (1.05 × 10⁴ J/m³), demonstrating that the measured strain reflects magnetoelastic coupling, phase constitution, microstructure, internal strain, and domain processes rather than anisotropy alone. The authors also stress that these values describe the bulk pellet response and do not quantify strain, torque, or force generated by individual nanoparticles dispersed in a biological medium.

The biological arm of the study examined the same materials, designated STA-0.5 through STA-1.1 by nominal cobalt content, against MCF-7 human breast cancer cells using MTT assays at concentrations from 62.5 to 1000 µg mL⁻¹ over 48 hours, all without an applied magnetic field. Every formulation inhibited cell growth in a concentration-dependent manner, but the cobalt-rich compositions were the most active: STA-1.1 (Co₁.₁Fe₁.₉O₄) and STA-1.0 (CoFe₂O₄) produced maximum growth inhibition of approximately 46.2 percent and 44.7 percent, respectively, at 1000 µg mL⁻¹. Iron-rich compositions STA-0.5 through STA-0.8 showed comparatively weaker effects, and STA-0.5 managed only about 5 percent inhibition at the lowest concentration. The cobalt-rich samples also retained relatively high activity at 62.5–250 µg mL⁻¹. Because no non-cancerous cell line was included, the authors interpret these results specifically as MCF-7 growth inhibition and explicitly caution that the data do not establish selective toxicity toward cancer cells.

Microscopy added morphological weight to the viability numbers. Separate phase-contrast and DAPI imaging experiments at 50, 100, and 200 µg mL⁻¹ showed a progressive loss of cell density and confluency with increasing concentration, along with more rounded and detached cells and enlarged cell-free regions at 100 and 200 µg mL⁻¹. DAPI nuclear staining revealed increasing nuclear condensation and fragmentation at the higher imaging concentrations, while untreated controls displayed uniform nuclei and normal morphology. The authors are careful about interpretation: these observations indicate cytotoxic damage but are not pathway-specific, so they do not by themselves establish apoptosis or any other specific cell-death mechanism. Confirmation, they note, would require assays such as Annexin V/PI flow cytometry, caspase-3/7 activation, and mitochondrial membrane-potential measurements.

Equally notable is what the study declines to claim. Intracellular reactive oxygen species generation, metal-ion release, nanoparticle uptake, and colloidal stability in biological media were not measured, so the composition-dependent growth inhibition cannot presently be assigned to a specific redox or oxidative-stress mechanism, even though Fe/Co-mediated oxidative stress has been reported for related ferrite systems and is flagged as a candidate for future work. The authors also point out a striking compositional mismatch: the largest pellet-scale magnetostriction occurred at x = 0.7, whereas the greatest zero-field MCF-7 growth inhibition occurred at x = 1.0 and x = 1.1. Because the biological assays used nanoparticle suspensions under zero-field conditions while magnetostriction was measured on sintered pellets, the two datasets are treated as independent outcomes, and the present data do not support a direct relationship between magnetostrictive magnitude and cellular response.

Within those boundaries, the study delivers a coherent composition–structure–magnetic–magnetostrictive framework for Co–Fe oxide nanomaterials together with a baseline zero-field biological assessment. The authors argue that non-stoichiometric composition provides an effective route for tuning the magnetoelastic response, and that the measured magnetostrictive properties offer a materials-level basis for future magnetic-field-assisted biomedical investigations in which nanoparticle-mediated mechanical effects can be directly evaluated under controlled external fields. Future work, they suggest, should include field-on/field-off biological comparisons, appropriate non-cancerous cell controls, intracellular ROS and ion-release measurements, cellular-uptake analysis, and pathway-specific cell-death assays. For now, the message is that a modest shift in the cobalt-to-iron ratio—not exotic doping or elaborate processing—can move coercivity, strain output, and cancer-cell growth inhibition in different directions, giving materials designers several independent dials to turn in cobalt ferrite nanomaterials.

Subject of Research: Composition-dependent magnetic, magnetostrictive, and in vitro cytotoxic properties of cobalt ferrite nanoparticles

Article Title: Stoichiometry-engineered cobalt ferrite-based nanomaterials with tunable magnetism, magnetostriction, and in vitro cytotoxicity

Article References: Gaikwad, A. S., Patil, M. R., Meena, S. S., Singh, G. P., Singh, J., Singh, S., Ibrahim, A. A., Gumathannavar, R., Fulari, A. V., Kadam, R. H., Wang, D., & Shirsath, S. E. (2026). Stoichiometry-engineered cobalt ferrite-based nanomaterials with tunable magnetism, magnetostriction, and in vitro cytotoxicity. Discover Nano, 21(1), Article 600. https://doi.org/10.1186/s11671-026-05074-8

Image Credits: AI Generated

DOI: 10.1186/s11671-026-05074-8

Keywords: cobalt ferrite, spinel ferrite, magnetostriction, coercivity, MCF-7 breast cancer cells, MTT assay, sol-gel auto-combustion, Rietveld refinement, Mössbauer spectroscopy, nanoparticles, magnetocrystalline anisotropy, zero-field cytotoxicity